Howard S Hochster MD

Rutgers-CINJ Associate Director for Clinical Research; Distinguished Prof RWJ Med School; Director Onc Research RWJBarnabas Health;

[Rutgers Cancer Institute @RutgersCancer]

Don’t miss @RutgersCancer @RWJBarnabas Associate Director for Population Science and Community Outreach as well as our
Director of Cancer Health Equity Center of Excellence, Dr. Anita Kinney, in booth #11025 today at #ASCO26! Learn about the exciting work happening in cancer prevention and population science. ⬇️

[Howard S Hochster MD @HH_Oncodr]

@CathyEngMD Necessity may be the mother of invention but she can be a mother to all of us !

[Dr. Cathy Eng @CathyEngMD]

I just learned #cancer #surgical icon of the #nonoperativemanagement approach to #rectalcancer Dr. Angelita Habr-Gama just passed away today at the age of 93. She was AMAZING! She has changed our views on the necessity of surgery in the setting of cCR. #groundbreaking #cancerresearch #originaldisruptor

[Rutgers Cancer Institute @RutgersCancer]

This #ClinicalTrialsDay, we recognize the critical role clinical trials play in advancing cancer care and research. With over 230 active cancer clinical trials, @RutgersCancer is turning these discoveries into new ways to prevent and treat cancer that is shaping the future of cancer care in New Jersey and beyond.

Learn more about cancer clinical trials available through @RutgersCancer and @RWJBarnabas: https://t.co/AgyNrfukMD

[Howard S Hochster MD @HH_Oncodr]

Great work @DrAEvens ! Appreciate your expertise and dedication. @RutgersCancer

[Rutgers Cancer Institute @RutgersCancer]

Congratulations to @RutgersCancer @RWJBarnabas Dr. Andrew Evens @DrAEvens on contributing to newly published international consensus guidelines in the Journal of Clinical Oncology @JCO_ASCO. This landmark publication addresses the management of hematologic cancers during pregnancy and reflects over a year of global collaboration through the International Network on Cancer, Infertility and Pregnancy (INCIP).

Read the publication: https://t.co/OSYvdGp2iu

[Howard S Hochster MD @HH_Oncodr]

Thanks Dr Eng. And also enrolling @RutgersCancer. Amivantamab already approved in lung cancer but hopefully equally effective for RAS non-mutated #coloncancer

[Dr. Cathy Eng @CathyEngMD]

Out of press! Amivantamab (fully human, bispecific IgG1 monoclonal antibody) that targets EGFR and MET Monotherapy in Chemorefractory RAS/BRAF Wild-Type Metastatic Colorectal Cancer: Results From OrigAMI-1, an Open-Label, Phase Ib/II Study | Journal of Clinical Oncology https://t.co/rnT512NMwM @ASCO #colorectalcancer #cancer
Enroll to #Origami2 (NCT06662786) and #Origami3 (NCT06750094) Vanderbilt University Medical Center

[Dr. Cathy Eng @CathyEngMD]

Out of press! Amivantamab (fully human, bispecific IgG1 monoclonal antibody) that targets EGFR and MET Monotherapy in Chemorefractory RAS/BRAF Wild-Type Metastatic Colorectal Cancer: Results From OrigAMI-1, an Open-Label, Phase Ib/II Study | Journal of Clinical Oncology https://t.co/rnT512NMwM @ASCO #colorectalcancer #cancer
Enroll to #Origami2 (NCT06662786) and #Origami3 (NCT06750094) Vanderbilt University Medical Center

[Howard S Hochster MD @HH_Oncodr]

Available @RutgersCancer for refractory gastric cancer. Call and we can test you for the KKLC1 antigen and HLA type. @RWJBarnabas #stomachcancer

[Rutgers Cancer Institute @RutgersCancer]

NOW OPEN @RutgersCancer: “A Phase I Trial of T Cell Receptor Gene Therapy Targeting KK-LC-1 for Cancers of the Stomach, Breast, Lung and Cervix.” #ClinicalTrial #CancerResearch @CSHinrichsMD @RWJBarnabas https://t.co/YL3m8TrXCY

[Howard S Hochster MD @HH_Oncodr]

👉Great opportunity!! Submit your research 👈

[JNCI @JNCI_Now]

📣 Last call! Submit your proposal on Cancer & Aging to JNCI, exploring mechanisms, interventions & policy for better outcomes. 📅 Deadline: Jan 9, 2026

Learn more: https://t.co/VNQdpWCpyl
@mandel_jeanne @HH_Oncodr @xrtGenomics @minasedrakmd

[Rutgers Cancer Institute @RutgersCancer]

For the 1 in 20 Americans facing a cancer diagnosis, new hope is not just a wish—it's essential. At @RutgersCancer and @RWJBarnabas, we’re dedicated to pioneering innovative treatments.

Together, we're inching closer to a cure every day!❤️

🔬 Learn more about cancer research happening at @RutgersCancer.

#MicroscopeMonday

[Howard S Hochster MD @HH_Oncodr]

We can test your tumor if you have refractory cancer with the diagnoses below. Contact us if you are interested in possibly receiving cellular therapy. @RutgersCancer

[Rutgers Cancer Institute @RutgersCancer]

NOW OPEN @RutgersCancer: “A Phase I Trial of T Cell Receptor Gene Therapy Targeting KK-LC-1 for Cancers of the Stomach, Breast, Lung and Cervix.” #ClinicalTrial #CancerResearch @CSHinrichsMD @RWJBarnabas https://t.co/YL3m8TrXCY

[Howard S Hochster MD @HH_Oncodr]

Happy holidays to everyone and especially to our patients @RutgersCancer #MorrisCC. And an especially joyous Holiday of Lights to those observing #Hanukkah. Our wonderful menorah in the #MorrisCC lobby bringing light to all.

[Rutgers Radiation Oncology Residency Program @RU_RadOnc]

Congrats to Mihir Patel on such an impressive accomplishment! @RutgersCancer

[Rutgers Cancer Institute @RutgersCancer]

On Friday, 12/12, @RutgersCancer @RWJBarnabas Dr. Mridula George @MridulaGeorgeMD presented “OCTANE: Adjuvant liposomal doxorubicin and carboplatin for early-stage triple negative breast cancer” at #SABCS25.

[Andrew M. Evens, DO, MBA, MSc @DrAEvens]

🚨🚨 With 93 peer-reviewed abstract presentations (including 33 podium/oral talks) combined with multiple invited educational talks at #ASH2025, there will be >100 total presentations on cutting edge science & key clinical breakthroughs given by our #bloodcancer and #classicalhematology experts!

[Rutgers Cancer Institute @RutgersCancer]

The @RutgersCancer @RWJBarnabas Annual Oncology Clinical Practice and Research Summit has started! Oncologists from across the Oncology Service Line will share the latest advancements in their disciplines over two days of enlightening sessions with @DrAEvens kicking off this insightful event! #CANCERNJ2025

[Rutgers Cancer Institute @RutgersCancer]

Thank you to our panelists Eric Carney, Bill Arnold, Alan Lee, and Rick Davis and moderator Susan Solometo on the @RWJBarnabas Transformative Investment in Oncology Services for a very informative panel session! #CancerNJ2025

@RWJUH @monmouthmedctr @monmouthsouth @CBMCNJ @CommunityMedNJ @rwjhamilton @RWJSomerset

[Andrew M. Evens, DO, MBA, MSc @DrAEvens]

🙌😄Thrilled to kickoff the @RutgersCancer @RWJBarnabas Annual Oncology Clinical Practice & Research Summit w/ nearly 500 attendees across our #beautiful service line; and honored to introduce our CEO and President, Mark Manigan, for his inspiring keynote lecture!

#CANCERNJ2025

[Howard S Hochster MD @HH_Oncodr]

Such a privilege to work with these outstanding and caring physicians @RutgersCancer #MorrisCancerCenter and @RWJBarnabas !

[Rutgers Cancer Institute @RutgersCancer]

Congratulations to all our @RutgersCancer @RWJBarnabas doctors who made it in New Jersey Monthly Magazine's Annual Top Doctors for 2025! 🎉

[Rutgers Cancer Institute @RutgersCancer]

🚨Groundbreaking research presentation! At #SITC25, @RWJBarnabas & @RutgersCancer’s @CSHinrichsMD unveiled results of TCR-T cells targeting HPV16 E7 in metastatic HPV-related cancers & data showing patients in remission 10 years after single TIL infusion.

Read more: https://t.co/H0YnaiuRZL @RutgersU
@rutgershealth @RWJMS